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http://www.ijbnpa.org/content/11/1/34METHODOLOGY Open AccessCombined influence of epoch length, cut-point
and bout duration on accelerometry-derived
physical activity
Mark Orme1,2, Katrien Wijndaele1, Stephen J Sharp1, Kate Westgate1, Ulf Ekelund1,3 and Soren Brage1*Abstract
Background: It is difficult to compare accelerometer-derived estimates of moderate-to-vigorous physical activity
(MVPA) between studies due to differences in data processing procedures. We aimed to evaluate the effects of
accelerometer processing options on total and bout-accumulated time spent in MVPA in adults.
Methods: 267 participants from the ProActive Trial provided 1236 days of valid physical activity (PA) data, collected
using a 5-s epoch with ActiGraph GT1M accelerometers. We integrated data over 5-s to 60-s epoch lengths (EL) and
applied two-level mixed effects regression models to MVPA time, defined using 1500 to 2500 counts/minute (cpm)
cut-points (CP) and bout durations (BD) from 1 to 15 min.
Results: Total MVPA time was lower on longer EL and higher CP (47 vs 26 min/day and 26 vs 5 min/day on 1500
vs 2500 cpm on 5-s and 60-s epoch, respectively); this could be approximated as MVPA = exp[2.197 + 0.279*log(CP)
+ 6.120*log(EL) - 0.869*log(CP)*log(EL)] with an 800 min/day wear-time. In contrast, EL was positively associated with
time spent in bout-accumulated MVPA; the approximating equation being MVPA = exp[54.679 - 6.268*log(CP) +
6.387*log(EL) - 10.000*log(BD) - 0.162*log(EL)*log(BD) - 0.626*log(CP)*log(EL) + 1.033*log(CP)*log(BD)]. BD and CP were
inversely associated with MVPA, with higher values attenuating the influence of EL.
Conclusions: EL, CP and BD interact to influence estimates of accelerometer-determined MVPA. In general, higher
CP and longer BD result in lower MVPA but the direction of association for EL depends on BD. Reporting scaling
coefficients for these key parameters across their frequently used ranges would facilitate comparisons of
population-level accelerometry estimates of MVPA.
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Regular moderate-to-vigorous physical activity (MVPA) is
beneficial for preventing non-communicable diseases [1].
Although the health benefits of participation in MVPA
have been well documented, population levels are believed
to be relatively low [2,3]. Despite extensive research inter-
est in physical activity (PA), there is limited data at the
population level, most of which is obtained in high-
income countries using self-report measures [2] which are
susceptible to several forms of bias [4].* Correspondence: soren.brage@mrc-epid.cam.ac.uk
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for the measurement of PA levels across different inten-
sities in observational and intervention studies has in-
creased over the last decade [5]. However, even with the
use of accelerometers, uncertainties remain with regards
to interpretation of the data generated. With advances in
technology, variability in data collection settings has in-
creased, presenting some challenges for comparisons be-
tween studies and with historical data.
Accelerometers were historically most often set-up to
record body movement at 60-s epochs [6], as this sam-
pling frequency permitted data collection for a longer dur-
ation compared with shorter epoch lengths with available
instruments [7]. Some studies have investigated the effect
of epoch duration on measured time spent in different PAtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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epochs should be used to obtain a more accurate repre-
sentation of young people’s PA levels [9]. This may well
hold true for adults as well, but to the best of our know-
ledge, there is only limited evidence on the effects of
epoch length in adults. A study by Gabriel et al. [10] com-
pared 10-s and 60-s epochs in overweight, postmeno-
pausal women and found higher total MVPA time when
data were presented in 10-s epochs. However, given the
homogenous sample used in the study, further research is
needed. So far, the majority of studies have examined ha-
bitual PA using 60-s epochs in healthy adults, and it is
therefore unclear how shorter epoch length settings might
influence estimates of MVPA in adults.
Another issue is the selection of cut-points for classifica-
tion of intensity levels, which has obvious implications for
estimating the proportion of time spent at various inten-
sities. Matthew [11] demonstrated the considerable variety
of cut-points that have been used, especially for MVPA.
The two cut-points predominantly used in adults to deter-
mine MVPA are 1952 counts-per-minute (cpm) for the
Actigraph accelerometer derived from the relationship be-
tween counts and energy expenditure during treadmill
walking and jogging [12], and 2020 cpm first used in
NHANES derived from a weighted average of all published
data available at the time of analysis [13]. Researchers may
wish to compare findings from studies using these cut-
points but with limited evidence to support their compar-
ability, illustrating the need to investigate the impact of
applying different cut-points, preferably in conjunction
with a range of epoch lengths, on time spent in MVPA.
Variability in the assessment of MVPA is not only re-
stricted to epoch and cut-point settings. Interpretation of
how MVPA can be accumulated in bouts of varying dur-
ation can also be brought into question. Current MVPA
guidelines [14] suggest that bouts of ≥10 mins are required
for health benefits. Most studies investigating bout-
accumulated MVPA defined a bout as ≥10 mins of continu-
ous activity above the cut-point threshold [15-17]. Ayabe
et al. [18] investigated bout durations of <32-s, >1 min, >3
mins and >5 mins in relation with health outcomes. How-
ever, there is limited evidence on the influence of allowing
shorter or longer bout lengths, and the interaction with
cut-point and epoch lengths, on time spent in MVPA in
adults.
We aimed to describe the scaling effects of epoch length
and cut-point selection on time spent in total MVPA, and
also on bout-accumulated MVPA including the effect of
bout duration.
Methods
Data
Data from the third wave of measurement of the Pro-
Active UK Trial were used for these analyses (n = 270).In brief, the aim of ProActive was to assess the efficacy
of a behavioural intervention designed to increase PA
levels among adults at high risk of type 2 diabetes. Full
details of the study can be found elsewhere [19]. Body
mass index was derived from objective measures of height
and weight. Bio-electrical impedance (Bodystat, Isle of
Man, UK) was used to estimate fat mass and fat-free mass.
Ethical approval was obtained from the Eastern Multi-
Centre Research Ethics Committee, and West Suffolk,
Cambridge, Huntingdon and West Essex Local Research
Ethics Committees and participants provided written in-
formed consent.
Assessment of free-living PA
The GT1M Actigraph (ActiGraph, LLC, Pensacola, FL)
uniaxial accelerometer was used to measure participants’
physical activity. The accelerometers were initialised to
collect data in 5-s epochs, worn on an elastic belt around
the waist for 5 days, and downloaded using ActiLife ver-
sion 4.3.0 (ActiGraph, LLC, Pensacola, FL).
Data processing
The accelerometer files were processed using KineSoft
version 3.3.63 (KineSoft, Saskatchewan, SK, Canada). For
the purpose of this investigation, copies of the original
files were made, and re-integrated into 10-s, 15-s, 20-s,
30-s and 60-s epochs resulting in six copies of each rec-
ord differentiated only by epoch length. The range and
number of epoch lengths investigated increase the power
of the regression models to establish scaling coefficients
and cover frequently used epoch lengths.
Non-wear time was defined as continuous runs of zeros
lasting ≥60 consecutive mins, with no allowance for
counts greater than zero. Participants removed the moni-
tor overnight and wear time was defined by subtracting
non-wear time (including sleep) from 24 h. Data were in-
cluded if participants accumulated a minimum of 500
mins (8 h 20 mins) of valid activity recordings per day for
at least 1 day.
Of the original sample of 270 participants with accelero-
metry data, two accelerometers were set up in 60-s
epochs, thus preventing the investigation of shorter epoch
lengths. One other accelerometer file was also excluded
from further analyses due to failure of meeting the valid
day criterion. The analysed sample therefore consisted of
267 individuals. To maximise estimation accuracy, daily
data was utilised resulting in 1236 valid days of accelerom-
eter output.
Statistical analyses
All statistical analyses were performed using STATA
12.0 (StataCorp, College Station, TX). Characteristics of
the study sample were described using means and stand-
ard deviations. Mean time spent in both total and bout-
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cut-point. To enable examination of curvilinear relation-
ships between accelerometer parameters and MVPA, all
variables were first log-transformed (natural). All models
were adjusted for wear time (truncated to ≥500 min/day),
as individuals wearing an accelerometer for longer each
day have a greater opportunity to accumulate MVPA.
The influences of epoch length (5-s, 10-s, 15-s, 20-s, 30-s
and 60-s) and MVPA cut-point (1500 cpm to 2500 cpm in
intervals of 100 cpm) on mean total time spent in MVPA
(natural log-transformed) were estimated using a 2-level
mixed effects regression model, with days of measurement
at level 1 nested within each participant at level 2. The ef-
fect of each covariate was estimated first by including each
one in a separate model, and then including all covariates
together. Cut-point values were rescaled proportionally
for data reintegration in 5-s, 10-s, 15-s, 20-s, and 30-s
epochs to calculate time spent engaging in MVPA (e.g. a
2000 cpm cut-point would be rescaled to a cut-point of
1000 counts per 30-s epoch). The interaction term between
cut-point and epoch length (both log-transformed) was also
included.
Bout-accumulated time spent in MVPA was defined as
continuous activity lasting more than a certain duration
above the cut-point threshold. The influences of bout dur-
ation (60-s, 120-s, 180-s, 300-s, 600-s and 900-s) on total
bout-accumulated time spent in MVPA was then investi-
gated, in conjunction with the effects of epoch length (5-s,
15-s, 30-s and 60-s) and cut-point (1500 cpm, 2000 cpm
and 2500 cpm), using a similar method to that described
above, and including all 2-way interactions.
Results
The mean wear time for this population was 842 mins
per day with 4.6 valid days per participant, on average.
Characteristics of the sample are shown in Table 1. The
final sample comprised of 153 women and 114 men with
a mean (SD) age of 48.2 (6.2) and 47.4 (5.6) years, re-
spectively. Overall, 41% and 35% of the participants were
classified as overweight and obese, respectively.
Total time spent in MVPA
Wear time was strongly associated with total time spent
in MVPA, for example person-days with a wear time ofTable 1 Descriptive characteristics of the study sample (n = 26
Women
n Mean ± SD
Age (yr) 153 48.2 ± 6.2 1
BMI (kg · m2) 153 29.0 ± 5.6 1
Fat free mass (kg) 142 48.2 ± 6.0 1
Fat mass (kg) 142 28.3 ± 10.9 1600 mins contained 40.1% (13mins 27 s) less MVPA
than those with 800 mins for an epoch length of 5-s and
a cut-point of 2020 cpm. All models therefore included
adjustment for wear time. The influence of epoch length
(5-s to 60-s), cut-point (1500 cpm to 2500 cpm) and
wear time (≥500 mins) on mean total time spent in
MVPA could be estimated using the following equation:
TotalMVPA minsð Þ ¼ exp0:279  log CutPointð Þ þ 6:120
log EpochLengthð Þ−0:869
log CutPointð Þ  log EpochLengthð Þ
þ 1:782  log WearTimeð Þ−9:715
All coefficients in this model are significant at p ≤ 0.004
(Additional file 1: Table S1). Over and above the variance
in total MVPA accounted for by wear time (4%), cut-point
and epoch length each explained about 8% of variance,
with their interaction adding another 0.9%.
Total MVPA time was inversely associated with both
epoch length and cut-point but the effects are somewhat
stronger at lower cut-points and shorter epochs, as indi-
cated by the opposite sign interaction term and shown
in Figure 1 panel A. Comparing the commonly used
1952 and 2020 cpm cut-points, there was a significant
difference in total time spent in MVPA of 4.1% (1 min
47 s; 95% CI = 6 s to 3mins 30s) for the 5-s epoch length.
This difference was similar but not statistically signifi-
cant for 15-s epochs (4.5%, 1 min 39 s; 95% CI = 0 s to
3mins 20s) nor for 60-s epochs (4.8%, 1 min 17 s; 95%
CI = 20s to 2mins 54 s). The effect of re-integrating 5-s
to 60-s epochs was a decrease in MVPA of 38.3%
(15mins 52 s; 95% CI = 14mins 6 s to 17mins 24 s) com-
pared with 15.8% (6mins 33 s; 95% CI = 4mins 54 s to
8mins 12 s) and 26.7% (9mins 19 s; 95% CI = 7mins 36 s
to 10mins 54 s) for 5-s to 15-s and 15-s to 60-s reinte-
gration, respectively. These differences by epoch length
using the 2020 cpm cut-point were similar when using
the 1952 cpm MVPA threshold.
Bout-accumulated time spent in MVPA
The influence of bout duration (60-s to 900-s), epoch
length (5-s to 60-s), cut-point (1500 cpm to 2500 cpm)
and wear time (≥500 mins) on mean bout-accumulated7)
Men All
n Mean ± SD n Mean ± SD
14 47.4 ± 5.6 267 47.9 ± 6.0
14 28.7 ± 4.5 267 28.9 ± 5.2
03 67.9 ± 9.5 245 56.5 ± 12.4
03 24.3 ± 8.8 245 26.6 ± 10.3
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Figure 1 Mean time spent in total and bout-accumulated moderate-to-vigorous physical activity, by epoch length. Legend; Total time
spent in moderate-to-vigorous physical activity (MVPA) is represented in panel A and bout-accumulated (>10 min) time spent in MVPA in panel
B. For illustrative purposes, three epoch lengths (5-s, 15-s and 60-s) are chosen to represent the range of epoch lengths analysed, with three cut-
points (1500 cpm, 2000 cpm and 2500 cpm) displayed for each epoch. Values are means with 95% confidence intervals (error bars) of empirical
data, estimated from ANOVA repeated measures.
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ing equation:
Bout−accumulated MVPA minsð Þ ¼ exp− 6:268  log CutPointð Þ
þ 6:387  log EpochLengthð Þ
− 10:000  log BoutDurationð Þ
− 0:162  log EpochLengthð Þ
log BoutDurationð Þ− 0:626
log CutPointð Þ  log EpochLengthð Þ
þ 1:033  log CutPointð Þ
log BoutDurationð Þ þ 2:147
log WearTimeð Þ þ 40:327
All coefficients in this model are significant at p < 0.001
(Additional file 1: Table S2). Bout duration accounted for
38% of the variance in bout-accumulated MVPA over and
above that explained by wear time (0.5%), with epochlength and cut-point jointly adding 4% and the three 2-
way interaction terms adding another 0.7%.
There was no significant difference (~3%) in time
spent in bout-accumulated MVPA between 1952 cpm
and 2020 cpm for all epochs (5-s: 7 s, 95% CI = −42 s
to 30s; 15-s: 8 s, 95% CI = −54 s to 36 s; 60-s: 16 s, 95%
CI = −1 min 24 s to 48 s). Figure 1 panel B demon-
strates the reverse epoch length effect on the time
spent in bout-accumulated MVPA (≥2000 cpm; ≥10 mins)
compared with total time in this intensity. The effect of
converting 5-s to 60-s epochs was a gain in bout-
accumulated MVPA of 64.4% (5mins 19 s; 95% CI = 4mins
24 s – 6mins 12 s) compared with 35.1% (1mins 35 s; 95%
CI = 42 s – 2mins 30s) and 45.2% (3mins 44 s; 95% CI =
2mins 54 s – 4mins 36 s) for 5-s to 15-s and 15-s to 60-s
reintegration, respectively. Bout duration significantly
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Analysing bout-accumulated time spent in MVPA using
10 min bouts resulted in 68.1% less time in MVPA, com-
pared to a 1 min bout length (17mins 42 s; 95% CI =
−16mins 18 s – 19mins), and a 33.6% reduction versus
5 min bouts (4mins 12 s; 95% CI = −2mins 54 s – 5mins
36 s). Using 1 min bouts resulted in a positive difference in
MVPA of 51.9% (13mins 30s; 95% CI = 12mins 6 s –
14mins 48 s), compared with a 5 min bout length.
Figure 2 highlights the influence of bout duration on time
spent in MVPA, and the interactions associated with cut-
point and epoch length. To summarise, time spent in bout-
accumulated MVPA is inversely associated with bout
duration and cut-point. There is a positive relationship with
epoch length for time spent in bout-accumulated MVPA
with significant interaction, so that epoch length has a lar-
ger influence on time spent in MVPA when shorter bout
durations are examined. Increasing bout duration reduces
time spent in MVPA, with the effect attenuated by higher
cut-point thresholds and epoch lengths. The mean effect
of selecting a 10 min bout duration (2000 cpm; 60-s) is a
decrease in time spent in MVPA of 49.4% (8mins 6 s; 95%
CI = 6mins 42 s – 9mins 24 s) compared with 3 min bouts.
For bouts of at least 10 mins (2000 cpm), integrating
epoch length from 5-s to 60-s increased time spent in
MVPA by 276% (5mins 18 s; 95% CI = 4mins 30s – 6mins
18 s). Increasing the cut-point from 1500 cpm to
2500 cpm (10 min bouts; 60-s) decreases time spent in
bout-accumulated MVPA by 48.5% (4mins 0 s; 95% CI =
2mins 54 s – 5mins 6 s).0
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Figure 2 Mean time spent in bout-accumulated moderate-to-
vigorous physical activity, by bout duration. Legend; Moderate-
to-vigorous physical activity (MVPA) cut-point threshold of 1500 cpm is
shown in panel A, 2000 cpm in panel B, and 2500 cpm in panel C. For
each panel, bout durations of ≥1 min, ≥3 mins, ≥5 mins and ≥10 mins
are given, with three epochs (5-s, 15-s and 60-s) for each bout criterion.
Values are means with 95% confidence intervals (error bars) of empirical
data, estimated from ANOVA repeated measures.Discussion
We investigated the combined influences of accelerometer
processing parameters across a range of epoch lengths, cut-
points and bout durations on time spent in total and bout-
accumulated MVPA in adults. Our findings highlight
the need to make informed decisions concerning the
processing and interpretation of accelerometer data.
The regression models reveal how time spent in total
and bout-accumulated MVPA are affected by epoch
length, cut-point and bout duration.
The standardisation of accelerometer-derived PA meas-
urement is a challenge within the field of objective moni-
toring. We have demonstrated that the data collection and
processing decisions contribute, both as independent and
interacting factors, to the estimated amount of time spent
in MVPA within a given population. Our analyses provide
insight into how participants tend to accumulate their ac-
tivity. For example, if total and bout-accumulated time
spent in MVPA is very different using shorter epochs, as is
the case in this current investigation, it can be concluded
that participants accumulate their MVPA in a relatively
sporadic nature. We therefore recommend that theseanalyses are conducted for other populations, providing
information on the effects of these parameters.
Epoch length and bout duration were found to interact;
there is a reverse association for epoch length between
total and bout-accumulated MVPA. Longer epochs result
in greater accumulation of MVPA in bouts due to a
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of bout termination by short interruptions. Conversely,
shorter epochs are more likely to end bouts of MVPA. The
effect of longer epochs on bout-accumulated time spent in
MVPA is attenuated by the use of higher cut-point thresh-
olds or longer bout durations. We used a continuous bout
definition in the present investigation and did not include
the concept of bout interruption allowances [15,20]. It is a
matter of definition if for example a 21-min segment of
MVPA with an interruption of 1 min in the middle is con-
sidered a single bout of 20 mins or two bouts of 10 mins.
Gabriel et al. [10] found more than 15 mins difference
in total time spent in MVPA between 60-s and 10-s
epochs in female adults which is comparable with the re-
sults of this study in men and women. Caution must
therefore be given to comparisons between adult PA in-
vestigations using accelerometry without adjustments for
epoch length, as these differences are likely to impact on
adherence to PA guidelines and associations with clinical
outcomes. As suggested by Gabriel et al. [10], intermittent
MVPA is likely to be misclassified as light intensity when
summed over a full minute. It is therefore not only the
sporadic nature of children’s activity [9] but also the inter-
mittent activity of adults which makes epoch length a sig-
nificant factor on the interpretation of accelerometer data.
Nilsson et al. [8] investigated the role of epoch length
in children, demonstrating that the magnitude of the
epoch effect is amplified among individuals with higher
activity levels. In children, this was predominantly seen
in the vigorous and very vigorous intensity categories
and only to a lesser degree in moderate intensity. It
seems likely, based on both total and bout-accumulated
time spent in MVPA and previous findings [10], that this
amplification is also present in adults but the effect is
shifted towards less vigorous intensities.
The finding that a longer epoch length results in in-
creased bout-accumulated time spent in MVPA is sup-
ported by Nilsson et al. [8]. For continuous 10 min bouts
of MVPA, large differences were found between 5-s, 15-s
and 60-s epochs, as few daily activities require moderate
intensity sustained for at least 10 consecutive mins. Using
a 60-s epoch allows activity to drop below the threshold of
MVPA temporarily, as counts are summed over the mi-
nute. Shorter epochs will capture this instance of lower in-
tensity, thus the observed difference between total and
bout-accumulated MVPA will depend on the relative pro-
portion of MVPA undertaken in steady-state for any given
population. As our results show, this epoch influence be-
comes important relative to the selection of shorter or
longer bout durations. This interaction between epoch
length and bout duration on MVPA should be considered
when comparing bout and non-bout MVPA estimates.
The extent to which epoch length impacts on bout-
accumulated MVPA serves to highlight an importantissue arising in the field of accelerometry. There is a grow-
ing interest in the field with regard to the accumulation of
MVPA in bouts. However, it is governed more severely by
epoch length compared to total time spent in MVPA. Con-
sequently the processing of bouts using shorter epochs, al-
though more accurately detecting lapses in activity, may
not reflect the underpinning physiology. In parallel to de-
veloping appropriate definitions and methods for deter-
mining bout-accumulated MVPA using shorter epochs,
further research into the health effects of varying bout du-
rations, and the allowance of interruptions within them, is
required.
The comparison between 1952 cpm [12] and 2020 cpm
[13] cut-points on total and bout-accumulated time spent
in MVPA found the two sets of cut-points to be reasonably
comparable across epochs. Fewer than two minutes differ-
ence (~5%) between the cut-points was observed in all
epochs for both total and bout-accumulated MVPA, thus
this difference is unlikely to greatly influence the conclu-
sions of studies assuming their comparability. Cut-point
values which are more distant on the movement intensity
continuum, however, result in significant differences in time
spent in MVPA as also observed in other populations; for
example every 500 cpm increase in cut-point between
1000 cpm to 2000 cpm resulted in a 50% reduction of
MVPA in older American adults taking part in NHANES
2003–6 (60-sec epochs), a pattern which was consistent
across age decades despite differences in absolute levels
[21]. The cut-point also interacts with epoch length in de-
termining the likelihood of counts averaging above the
chosen MVPA threshold. The effect of selecting a higher
cut-point diminishes bout-accumulated MVPA to a lesser
degree with longer bout durations.
Wear time was found to be associated with time spent
in MVPA. It appears that wear time bias or selection ef-
fects may exist in relation to time spent in MVPA. How-
ever, the extent to which wear time contributes to the
overall effects of accelerometer processing criteria may de-
pend on multiple factors, including the activity level of the
population. It may be that those who do more MVPA are
more likely to wear the monitor for longer on average
each day. It could also be that wearing the accelerometer
for longer simply provides greater opportunity to accumu-
late MVPA. This finding adds to that of Pettee Gabriel
et al. [22] and Schmidt et al. [23] linking wear time with
sedentary behaviours. It is therefore recommended that
researchers not only specify non-wear detection criteria
for the time-series processing (e.g. zero-string length) and
minimum wear time criteria, including monitored days,
but also report the (truncated) mean wear time of the
sample and how it influences the activity outcome in
question.
This study highlights the need for researchers to con-
sider sample characteristics when investigating bout
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time spent in MVPA differs substantially when bouts are
introduced. The ProActive cohort is relatively inactive;
of the 98,556 days of data analysed (differentiated by dif-
ferent settings of epoch length, cut-point or bout length
for each participant), 48,581 days (49.3%) contained no
MVPA whatsoever and 64,636 days (65.6%) had fewer
than 10 mins of bout-accumulated MVPA.
There are important limitations to consider when
interpreting the results of the current investigation. We
only examined the influence of epoch in the 5-s to 60-s
range, the effect of MVPA cut-point in the 1500 cpm to
2500 cpm range, and the effect of bout duration in the
1 min to 15 min range; it is unlikely that the established
relationships hold true outside those ranges. In addition,
the relatively small sample size means analyses using lar-
ger, more heterogeneous populations are needed to es-
tablish the generalizability of these findings. However,
the relative inactivity of this population means the esti-
mated scaling effects of these processing criteria are
likely to be conservative.
Technological advancements in accelerometry have in-
creased the capabilities of available data collection, pro-
cessing methods and interpretation of activity estimates.
Accelerometers are now capable of collecting data using
1-s epochs or even raw acceleration. This can then be used
in conjunction with emerging signal processing and pat-
tern recognition models such as artificial neural networks
[7,24] to infer activity type and potentially also enhance
the assessment of MVPA. Despite these advances, the is-
sues raised in the current study will remain applicable as
the challenge of developing standardised methods of cate-
gorising population activity levels using accelerometry will
still exist. The advancements in accelerometer technology
means researchers are faced with a large number of deci-
sions with regards to the processing and interpretation of
PA data. Cut-point selection, epoch length and bout dur-
ation have all been identified as influencing MVPA out-
comes. We would encourage researchers to collect PA
data in the highest available resolution and replicate the
analyses of the current investigation to establish regression
coefficients for these three parameters in other popula-
tions. This enables greater understanding of how popula-
tions accumulate activity of a particular intensity, duration
and frequency. The present analyses also highlight the
need for investigations into the physiological impact of
bout-accumulated MVPA in parallel to advances in accel-
erometer processing.
Conclusions
In conclusion, methodological issues with regards to the
processing and interpretation of accelerometer-derived
time spent in MVPA in adults have been identified. The
selection of epoch length, cut-point threshold and boutduration influences MVPA outcomes as independent
and interacting parameters. It is recommended that re-
searchers use the highest accelerometer resolution available
in order to maximise the opportunities for summarising
the data appropriately with respects to epoch length, cut-
point and bout duration in comparisons with existing
population data. When this is not directly possible, the de-
scription of population levels of MVPA across a range of
these settings allows for a more standardised methodology
for accelerometer-based PA.
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